These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16724943)

  • 1. Anti-oxidant gene therapy by NF kappa B decoy oligodeoxynucleotide.
    Nakagami H; Tomita N; Kaneda Y; Ogihara T; Morishita R
    Curr Pharm Biotechnol; 2006 Apr; 7(2):95-100. PubMed ID: 16724943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.
    Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M
    Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.
    Matsushita H; Morishita R; Nata T; Aoki M; Nakagami H; Taniyama Y; Yamamoto K; Higaki J; Yasufumi K; Ogihara T
    Circ Res; 2000 May; 86(9):974-81. PubMed ID: 10807870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.
    Tomita T; Takano H; Tomita N; Morishita R; Kaneko M; Shi K; Takahi K; Nakase T; Kaneda Y; Yoshikawa H; Ochi T
    Rheumatology (Oxford); 2000 Jul; 39(7):749-57. PubMed ID: 10908694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of NFkappaB inhibitor for arthritis].
    Tomita T; Kunugiza Y; Nomura K; Morimoto D; Kuroda S; Yoshikawa H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):71-6. PubMed ID: 19404004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases.
    Mehta M; Paudel KR; Shukla SD; Allam VSRR; Kannaujiya VK; Panth N; Das A; Parihar VK; Chakraborty A; Ali MK; Jha NK; Xenaki D; Su QP; Wich PR; Adams J; Hansbro PM; Chellappan DK; Oliver BGG; Dua K
    J Control Release; 2021 Sep; 337():629-644. PubMed ID: 34375688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of neointimal formation after angioplasty using nuclear factor-κB decoy oligodeoxynucleotide-coated balloon catheter in rabbit model.
    Miyake T; Ihara S; Miyake T; Tsukada Y; Watanabe H; Matsuda H; Kiguchi H; Tsujimoto H; Nakagami H; Morishita R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):787-96. PubMed ID: 25406205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
    Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T
    Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts.
    Shimizu H; Nakagami H; Tsukamoto I; Morita S; Kunugiza Y; Tomita T; Yoshikawa H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2006 Jun; 13(12):933-41. PubMed ID: 16511526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3/NF‑κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF‑κB signaling pathway in a mouse model of atherosclerosis.
    An HJ; Gwon MG; Gu H; Bae S; Leem J; Lee JB; Park KK
    Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.
    Xu MQ; Suo YP; Gong JP; Zhang MM; Yan LN
    World J Gastroenterol; 2004 Aug; 10(16):2361-8. PubMed ID: 15285020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs).
    Wang Z; Potoyan DA; Wolynes PG
    BMC Syst Biol; 2018 Jan; 12(1):4. PubMed ID: 29382384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model.
    Miyake T; Aoki M; Masaki H; Kawasaki T; Oishi M; Kataoka K; Ogihara T; Kaneda Y; Morishita R
    Circ Res; 2007 Nov; 101(11):1175-84. PubMed ID: 17885220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats.
    Yokoseki O; Suzuki J; Kitabayashi H; Watanabe N; Wada Y; Aoki M; Morishita R; Kaneda Y; Ogihara T; Futamatsu H; Kobayashi Y; Isobe M
    Circ Res; 2001 Nov; 89(10):899-906. PubMed ID: 11701617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts.
    Azuma H; Tomita N; Kaneda Y; Koike H; Ogihara T; Katsuoka Y; Morishita R
    Gene Ther; 2003 Mar; 10(5):415-25. PubMed ID: 12601396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
    Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K
    Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T
    Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.